David R. Andes - Publications

Affiliations: 
Cellular and Molecular Biology University of Wisconsin, Madison, Madison, WI 
Area:
Antifungal drug resistance, Microbiology Biology, Molecular Biology
Website:
https://www.medicine.wisc.edu/infectiousdisease/andesresearch

116 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR. Pharmacodynamic Evaluation of Omadacycline against in the Neutropenic Mouse Pneumonia Model. Antimicrobial Agents and Chemotherapy. PMID 31712210 DOI: 10.1128/AAC.02058-19  0.68
2019 Rai LS, Singha R, Sanchez H, Chakraborty T, Chand B, Bachellier-Bassi S, Chowdhury S, d'Enfert C, Andes DR, Sanyal K. The Candida albicans biofilm gene circuit modulated at the chromatin level by a recent molecular histone innovation. Plos Biology. 17: e3000422. PMID 31398188 DOI: 10.1371/journal.pbio.3000422  0.4
2019 Zhao M, Lepak AJ, Marchillo K, Andes DR. Pharmacodynamic Target Determination for Delafloxacin against and in the Neutropenic Murine Pneumonia Model. Antimicrobial Agents and Chemotherapy. PMID 31332063 DOI: 10.1128/AAC.01131-19  0.68
2019 Rodríguez López AL, Lee MR, Wang NB, Dunn KK, Sanchez H, Raman N, Andes DR, Lynn DM, Palecek SP. Small-molecule morphogenesis modulators enhance the ability of 14-helical β-peptides to prevent biofilm formation. Antimicrobial Agents and Chemotherapy. PMID 31209011 DOI: 10.1128/AAC.02653-18  0.4
2019 Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR. Pharmacodynamics of Omadacycline against in the Neutropenic Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. PMID 31036691 DOI: 10.1128/AAC.00624-19  0.68
2018 Robinett NG, Culbertson EM, Peterson RL, Sanchez H, Andes D, Nett JE, Culotta VC. Exploiting the vulnerable active site of a copper-only superoxide dismutase to disrupt fungal pathogenesis. The Journal of Biological Chemistry. PMID 30593499 DOI: 10.1074/jbc.RA118.007095  0.92
2018 Zarnowski R, Sanchez H, Covelli AS, Dominguez E, Jaromin A, Berhardt J, Heiss C, Azadi P, Mitchell A, Andes DR. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. Plos Biology. 16: e2006872. PMID 30296253 DOI: 10.1371/journal.pbio.2006872  0.4
2018 Dijck PV, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, et al. Methodologies for and evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. Microbial Cell (Graz, Austria). 5: 300-326. PMID 29992128 DOI: 10.15698/mic2018.07.638  0.92
2018 Zhao M, Lepak AJ, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Characterization of a Novel Antibiotic Odilorhabdins, NOSO-502 against and in a Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. PMID 29987156 DOI: 10.1128/AAC.01067-18  0.68
2018 Jaromin A, Zarnowski R, Piętka-Ottlik M, Andes DR, Gubernator J. Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity. Nanomedicine (London, England). 13: 1139-1155. PMID 29873597 DOI: 10.2217/nnm-2017-0337  0.36
2018 Kim D, Liu Y, Benhamou RI, Sanchez H, Simón-Soro Á, Li Y, Hwang G, Fridman M, Andes DR, Koo H. Bacterial-derived exopolysaccharides enhance antifungal drug tolerance in a cross-kingdom oral biofilm. The Isme Journal. PMID 29670217 DOI: 10.1038/s41396-018-0113-1  0.4
2018 Dominguez E, Zarnowski R, Sanchez H, Covelli AS, Westler WM, Azadi P, Nett J, Mitchell AP, Andes DR. Conservation and Divergence in theSpecies Biofilm Matrix Mannan-Glucan Complex Structure, Function, and Genetic Control. Mbio. 9. PMID 29615504 DOI: 10.1128/mBio.00451-18  0.44
2018 Park JH, Craig W, Marchillo K, Huang DB, Andes DR. Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Drivers of Iclaprim. Antimicrobial Agents and Chemotherapy. PMID 29378717 DOI: 10.1128/AAC.02550-17  0.68
2018 Zhao M, Lepak AJ, VanScoy B, Bader JC, Marchillo K, Vanhecker J, Ambrose PG, Andes DR. In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model. Antimicrobial Agents and Chemotherapy. PMID 29378706 DOI: 10.1128/AAC.02542-17  0.68
2017 Rossi DCP, Gleason JE, Sanchez H, Schatzman SS, Culbertson EM, Johnson CJ, McNees CA, Coelho C, Nett JE, Andes DR, Cormack BP, Culotta VC. Candida albicans FRE8 encodes a member of the NADPH oxidase family that produces a burst of ROS during fungal morphogenesis. Plos Pathogens. 13: e1006763. PMID 29194441 DOI: 10.1371/journal.ppat.1006763  0.92
2017 Srivastava A, Sircaik S, Husain F, Thomas E, Ror S, Rastogi S, Alim D, Bapat P, Andes DR, Nobile CJ, Panwar SL. Distinct roles of the 7-transmembrane receptor protein Rta3 in regulating the asymmetric distribution of phosphatidylcholine across the plasma membrane and biofilm formation in Candida albicans. Cellular Microbiology. PMID 28745020 DOI: 10.1111/cmi.12767  0.44
2017 Zhao M, Lepak AJ, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia Coli in a Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. PMID 28416552 DOI: 10.1128/AAC.00250-17  0.68
2017 Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR. In vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model. Antimicrobial Agents and Chemotherapy. PMID 28193651 DOI: 10.1128/AAC.02368-16  0.68
2016 Woolford CA, Lagree K, Xu W, Aleynikov T, Adhikari H, Sanchez H, Cullen PJ, Lanni F, Andes DR, Mitchell AP. Bypass of Candida albicans Filamentation/Biofilm Regulators through Diminished Expression of Protein Kinase Cak1. Plos Genetics. 12: e1006487. PMID 27935965 DOI: 10.1371/journal.pgen.1006487  0.44
2016 Zarnowski R, Sanchez H, Andes DR. Large-scale production and isolation of Candida biofilm extracellular matrix. Nature Protocols. 11: 2320-2327. PMID 27809313 DOI: 10.1038/nprot.2016.132  0.4
2016 Mitchell KF, Zarnowski R, Andes DR. Fungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions. Plos Pathogens. 12: e1005828. PMID 27685086 DOI: 10.1371/journal.ppat.1005828  0.92
2016 Winter MB, Salcedo EC, Lohse MB, Hartooni N, Gulati M, Sanchez H, Takagi J, Hube B, Andes DR, Johnson AD, Craik CS, Nobile CJ. Global Identification of Biofilm-Specific Proteolysis in Candida albicans. Mbio. 7. PMID 27624133 DOI: 10.1128/mBio.01514-16  0.44
2016 Dalal CK, Zuleta IA, Mitchell KF, Andes DR, El-Samad H, Johnson AD. Transcriptional rewiring over evolutionary timescales changes quantitative and qualitative properties of gene expression. Elife. 5. PMID 27614020 DOI: 10.7554/eLife.18981  0.52
2016 Mitchell KF, Zarnowski R, Andes DR. The Extracellular Matrix of Fungal Biofilms. Advances in Experimental Medicine and Biology. PMID 27271680 DOI: 10.1007/5584_2016_6  0.92
2016 Nett JE, Cabezas-Olcoz J, Marchillo K, Mosher DF, Andes DR. Targeting fibronectin to disrupt in vivo Candida biofilms. Antimicrobial Agents and Chemotherapy. PMID 26902759 DOI: 10.1128/AAC.03094-15  0.92
2016 Raman N, Marchillo K, Lee MR, Rodríguez López AL, Andes DR, Palecek SP, Lynn DM. Intraluminal Release of an Antifungal β-Peptide Enhances the Antifungal and Anti-Biofilm Activities of Multilayer-Coated Catheters in a Rat Model of Venous Catheter Infection. Acs Biomaterials Science & Engineering. 2: 112-121. PMID 26807439 DOI: 10.1021/acsbiomaterials.5b00427  0.92
2016 Nett JE, Andes DR. Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infectious Disease Clinics of North America. 30: 51-83. PMID 26739608 DOI: 10.1016/j.idc.2015.10.012  0.92
2016 Lepak AJ, Seiler P, Surivet JP, Ritz D, Kohl C, Andes DR. In vivo pharmacodynamic target investigation of two bacterial topoisomerase inhibitors, ACT-387042 and ACT-292706, in the neutropenic murine thigh model against Streptococcus pneumoniae and Staphylococcus aureus Antimicrobial Agents and Chemotherapy. 60: 3626-3632. DOI: 10.1128/AAC.00363-16  0.92
2015 Sidoryk K, Świtalska M, Jaromin A, Cmoch P, Bujak I, Kaczmarska M, Wietrzyk J, Dominguez EG, Żarnowski R, Andes DR, Bańkowski K, Cybulski M, Kaczmarek Ł. The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: Highly selective cytotoxic agents. European Journal of Medicinal Chemistry. 105: 208-19. PMID 26496013 DOI: 10.1016/j.ejmech.2015.10.022  0.36
2015 Nett JE, Andes DR. Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs. Microbiology Spectrum. 3. PMID 26397003 DOI: 10.1128/microbiolspec.MB-0008-2014  0.92
2015 Nett JE, Zarnowski R, Cabezas-Olcoz J, Brooks EG, Bernhardt J, Marchillo K, Mosher DF, Andes DR. Host Contributions to Construction of Three Device-Associated Candida albicans Biofilms. Infection and Immunity. 83: 4630-8. PMID 26371129 DOI: 10.1128/IAI.00931-15  0.92
2015 Lepak AJ, Parhi A, Madison M, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model. Antimicrobial Agents and Chemotherapy. 59: 6568-74. PMID 26259789 DOI: 10.1128/AAC.01464-15  0.92
2015 Davis SA, Vincent BM, Endo MM, Whitesell L, Marchillo K, Andes DR, Lindquist S, Burke MD. Nontoxic antimicrobials that evade drug resistance. Nature Chemical Biology. 11: 481-7. PMID 26030729 DOI: 10.1038/nchembio.1821  0.92
2015 Fox EP, Bui CK, Nett JE, Hartooni N, Mui MC, Andes DR, Nobile CJ, Johnson AD. An expanded regulatory network temporally controls Candida albicans biofilm formation. Molecular Microbiology. 96: 1226-39. PMID 25784162 DOI: 10.1111/mmi.13002  0.92
2015 Mitchell KF, Zarnowski R, Sanchez H, Edward JA, Reinicke EL, Nett JE, Mitchell AP, Andes DR. Community participation in biofilm matrix assembly and function. Proceedings of the National Academy of Sciences of the United States of America. 112: 4092-7. PMID 25770218 DOI: 10.1073/pnas.1421437112  0.92
2015 Lepak AJ, Marchillo K, Andes DR. Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model. Antimicrobial Agents and Chemotherapy. 59: 1265-72. PMID 25512406 DOI: 10.1128/AAC.04445-14  0.92
2015 Lepak AJ, Marchillo K, Craig WA, Andes DR. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model. Antimicrobial Agents and Chemotherapy. 59: 1258-64. PMID 25512404 DOI: 10.1128/AAC.04444-14  0.92
2015 Lepak AJ, Andes DR. Antifungal pharmacokinetics and pharmacodynamics. Cold Spring Harbor Perspectives in Medicine. 5: a019653. PMID 25384765 DOI: 10.1101/cshperspect.a019653  0.92
2014 Desai JV, Mitchell AP, Andes DR. Fungal biofilms, drug resistance, and recurrent infection. Cold Spring Harbor Perspectives in Medicine. 4. PMID 25274758 DOI: 10.1101/cshperspect.a019729  0.92
2014 Nett JE, Brooks EG, Cabezas-Olcoz J, Sanchez H, Zarnowski R, Marchillo K, Andes DR. Rat indwelling urinary catheter model of Candida albicans biofilm infection. Infection and Immunity. 82: 4931-40. PMID 25183731 DOI: 10.1128/IAI.02284-14  0.92
2014 Zarnowski R, Westler WM, Lacmbouh GA, Marita JM, Bothe JR, Bernhardt J, Lounes-Hadj Sahraoui A, Fontaine J, Sanchez H, Hatfield RD, Ntambi JM, Nett JE, Mitchell AP, Andes DR. Novel entries in a fungal biofilm matrix encyclopedia. Mbio. 5: e01333-14. PMID 25096878 DOI: 10.1128/mBio.01333-14  0.92
2014 Boehme AK, McGwin G, Andes DR, Lyon GM, Chiller T, Pappas PG, Baddley JW. Race and invasive fungal infection in solid organ transplant recipients. Ethnicity & Disease. 24: 382-5. PMID 25065083  0.92
2014 Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, Franks B, Azie NE. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. Plos One. 9: e101510. PMID 24991967 DOI: 10.1371/journal.pone.0101510  0.92
2014 Nobile CJ, Fox EP, Hartooni N, Mitchell KF, Hnisz D, Andes DR, Kuchler K, Johnson AD. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans. Mbio. 5: e01201-14. PMID 24917598 DOI: 10.1128/mBio.01201-14  0.92
2014 Sidoryk K, Jaromin A, Edward JA, Åšwitalska M, StefaÅ„ska J, Cmoch P, Zagrodzka J, Szczepek W, PeczyÅ„ska-Czoch W, Wietrzyk J, Kozubek A, Zarnowski R, Andes DR, Kaczmarek Ł. Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities. European Journal of Medicinal Chemistry. 78: 304-13. PMID 24686017 DOI: 10.1016/j.ejmech.2014.03.060  0.92
2014 Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, Knapp KM, Lyon GM, Marr KA, Morrison VA, Park BJ, et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transplant Infectious Disease : An Official Journal of the Transplantation Society. 16: 213-24. PMID 24589027 DOI: 10.1111/tid.12186  0.92
2014 Lewis JS, Lepak AJ, Thompson GR, Craig WA, Andes DR, Sabol-Dzintars KE, Jorgensen JH. Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections. Antimicrobial Agents and Chemotherapy. 58: 1327-31. PMID 24323478 DOI: 10.1128/AAC.01877-13  0.92
2014 Ng JK, Schulz LT, Rose WE, Fox BC, Andes DR, Buhr KA, Fish JT. Daptomycin dosing based on ideal body weight versus actual body weight: comparison of clinical outcomes. Antimicrobial Agents and Chemotherapy. 58: 88-93. PMID 24145531 DOI: 10.1128/AAC.01018-13  0.92
2013 Taff HT, Marchillo K, Andes DR. Preparation of Candida albicans Biofilms Using an in vivo Rat Central Venous Catheter Model. Bio-Protocol. 3. PMID 25927075  1
2013 Taff HT, Andes DR. Preparation of Candida albicans Biofilms for Transmission Electron Microscopy. Bio-Protocol. 3. PMID 25927074  1
2013 Seyedmousavi S, Mouton JW, Verweij PE, Andes DR. Continuous infusion of amphotericin B deoxycholate for the treatment of life-threatening Candida infections. American Journal of Respiratory and Critical Care Medicine. 188: 1033. PMID 24127804 DOI: 10.1164/rccm.201304-0668LE  0.92
2013 Lepak AJ, Marchillo K, Vanhecker J, Andes DR. Isavuconazole (BAL4815) pharmacodynamic target determination in an in vivo murine model of invasive pulmonary aspergillosis against wild-type and cyp51 mutant isolates of Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 57: 6284-9. PMID 24100500 DOI: 10.1128/AAC.01355-13  0.92
2013 Taff HT, Mitchell KF, Edward JA, Andes DR. Mechanisms of Candida biofilm drug resistance. Future Microbiology. 8: 1325-37. PMID 24059922 DOI: 10.2217/fmb.13.101  0.92
2013 Lepak AJ, Marchillo K, VanHecker J, Diekema D, Andes DR. Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model. Antimicrobial Agents and Chemotherapy. 57: 5642-8. PMID 24002092 DOI: 10.1128/AAC.01354-13  0.92
2013 Zhang J, Ponomareva LV, Marchillo K, Zhou M, Andes DR, Thorson JS. Synthesis and antibacterial activity of doxycycline neoglycosides. Journal of Natural Products. 76: 1627-36. PMID 23987662 DOI: 10.1021/np4003096  0.92
2013 Lepak AJ, Marchillo K, VanHecker J, Andes DR. Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates. Antimicrobial Agents and Chemotherapy. 57: 5438-47. PMID 23959322 DOI: 10.1128/AAC.00833-13  0.92
2013 Andes DR, Reynolds DK, Van Wart SA, Lepak AJ, Kovanda LL, Bhavnani SM. Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimization. Antimicrobial Agents and Chemotherapy. 57: 5714-6. PMID 23959319 DOI: 10.1128/AAC.01057-13  0.92
2013 Green JV, Orsborn KI, Zhang M, Tan QK, Greis KD, Porollo A, Andes DR, Long Lu J, Hostetter MK. Heparin-binding motifs and biofilm formation by Candida albicans. The Journal of Infectious Diseases. 208: 1695-704. PMID 23904295 DOI: 10.1093/infdis/jit391  0.92
2013 Connolly LA, Riccombeni A, Grózer Z, Holland LM, Lynch DB, Andes DR, Gácser A, Butler G. The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosis. Molecular Microbiology. 90: 36-53. PMID 23895281 DOI: 10.1111/mmi.12345  0.92
2013 Palmer JM, Bok JW, Lee S, Dagenais TR, Andes DR, Kontoyiannis DP, Keller NP. Loss of CclA, required for histone 3 lysine 4 methylation, decreases growth but increases secondary metabolite production in Aspergillus fumigatus. Peerj. 1: e4. PMID 23638376 DOI: 10.7717/peerj.4  0.92
2013 Desai JV, Bruno VM, Ganguly S, Stamper RJ, Mitchell KF, Solis N, Hill EM, Xu W, Filler SG, Andes DR, Fanning S, Lanni F, Mitchell AP. Regulatory role of glycerol in Candida albicans biofilm formation. Mbio. 4: e00637-12. PMID 23572557 DOI: 10.1128/mBio.00637-12  0.92
2013 Mitchell KF, Taff HT, Cuevas MA, Reinicke EL, Sanchez H, Andes DR. Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms. Antimicrobial Agents and Chemotherapy. 57: 1918-20. PMID 23318790 DOI: 10.1128/AAC.02378-12  0.92
2013 Lee DG, Murakami Y, Andes DR, Craig WA. Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice. Antimicrobial Agents and Chemotherapy. 57: 1434-41. PMID 23295932 DOI: 10.1128/AAC.00362-12  0.92
2013 Craig WA, Andes DR. In vivo activities of ceftolozane, a new cephalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended-spectrum β-lactamases, in the thighs of neutropenic mice Antimicrobial Agents and Chemotherapy. 57: 1577-1582. PMID 23274659 DOI: 10.1128/AAC.01590-12  0.92
2013 Lepak AJ, Marchillo K, Vanhecker J, Andes DR. Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy. 57: 579-85. PMID 23147740 DOI: 10.1128/AAC.01279-12  0.92
2013 Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Medical Mycology. 51: 128-35. PMID 22680976 DOI: 10.3109/13693786.2012.690108  0.92
2012 Peltier-Pain P, Marchillo K, Zhou M, Andes DR, Thorson JS. Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylation. Organic Letters. 14: 5086-9. PMID 22984807 DOI: 10.1021/ol3023374  0.92
2012 Lepak AJ, Marchillo K, Pichereau S, Craig WA, Andes DR. Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model. Antimicrobial Agents and Chemotherapy. 56: 5916-22. PMID 22964254 DOI: 10.1128/AAC.01303-12  0.92
2012 Taff HT, Nett JE, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. Plos Pathogens. 8: e1002848. PMID 22876186 DOI: 10.1371/journal.ppat.1002848  0.92
2012 Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 1110-22. PMID 22412055 DOI: 10.1093/cid/cis021  0.92
2012 Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Woolford CA, Nett JE, Taff H, Norice CT, Andes DR, Lanni F, Mitchell AP. Portrait of Candida albicans adherence regulators. Plos Pathogens. 8: e1002525. PMID 22359502 DOI: 10.1371/journal.ppat.1002525  0.92
2012 Nett JE, Marchillo K, Andes DR. Modeling of fungal biofilms using a rat central vein catheter. Methods in Molecular Biology (Clifton, N.J.). 845: 547-56. PMID 22328403 DOI: 10.1007/978-1-61779-539-8_40  0.92
2012 Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 148: 126-38. PMID 22265407 DOI: 10.1016/j.cell.2011.10.048  0.92
2012 Taff HT, Nett JE, Andes DR. Comparative analysis of Candida biofilm quantitation assays. Medical Mycology. 50: 214-8. PMID 21539503 DOI: 10.3109/13693786.2011.580016  0.92
2011 Lepak AJ, Andes DR. Antifungal PK/PD considerations in fungal pulmonary infections. Seminars in Respiratory and Critical Care Medicine. 32: 783-94. PMID 22167406 DOI: 10.1055/s-0031-1295726  0.92
2011 Ding C, Vidanes GM, Maguire SL, Guida A, Synnott JM, Andes DR, Butler G. Conserved and divergent roles of Bcr1 and CFEM proteins in Candida parapsilosis and Candida albicans. Plos One. 6: e28151. PMID 22145027 DOI: 10.1371/journal.pone.0028151  0.92
2011 Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito JI, Kauffman CA, Lyon GM, et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerging Infectious Diseases. 17: 1855-64. PMID 22000355 DOI: 10.3201/eid1710.110087  0.92
2011 Finkel JS, Yudanin N, Nett JE, Andes DR, Mitchell AP. Application of the systematic "DAmP" approach to create a partially defective C. albicans mutant. Fungal Genetics and Biology : Fg & B. 48: 1056-61. PMID 21820070 DOI: 10.1016/j.fgb.2011.07.005  0.92
2011 Lockhart SR, Zimbeck AJ, Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Pappas PG, Chiller T. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrobial Agents and Chemotherapy. 55: 3944-6. PMID 21670187 DOI: 10.1128/AAC.00428-11  0.92
2011 Nett JE, Sanchez H, Cain MT, Ross KM, Andes DR. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryotic Cell. 10: 1660-9. PMID 21666076 DOI: 10.1128/EC.05126-11  0.92
2011 Lockhart SR, Wagner D, Iqbal N, Pappas PG, Andes DR, Kauffman CA, Brumble LM, Hadley S, Walker R, Ito JI, Baddley JW, Chiller T, Park BJ. Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006. Journal of Clinical Microbiology. 49: 2404-10. PMID 21562099 DOI: 10.1128/JCM.02474-10  0.92
2011 Chen YL, Brand A, Morrison EL, Silao FG, Bigol UG, Malbas FF, Nett JE, Andes DR, Solis NV, Filler SG, Averette A, Heitman J. Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis. Eukaryotic Cell. 10: 803-19. PMID 21531874 DOI: 10.1128/EC.00310-10  0.92
2011 Nett JE, Cain MT, Crawford K, Andes DR. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. Journal of Clinical Microbiology. 49: 1426-33. PMID 21227984 DOI: 10.1128/JCM.02273-10  0.92
2011 Andes DR, Dismukes WE. Azoles Essentials of Clinical Mycology: Second Edition. 61-93. DOI: 10.1007/978-1-4419-6640-7_5  0.92
2010 Craig WA, Andes DR, Stamstad T. In vivo pharmacodynamics of new lipopeptide MX-2401 Antimicrobial Agents and Chemotherapy. 54: 5092-5098. PMID 20855736 DOI: 10.1128/AAC.00238-10  0.92
2010 Nett JE, Marchillo K, Spiegel CA, Andes DR. Development and validation of an in vivo Candida albicans biofilm denture model. Infection and Immunity. 78: 3650-9. PMID 20605982 DOI: 10.1128/IAI.00480-10  0.92
2010 Nett JE, Crawford K, Marchillo K, Andes DR. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrobial Agents and Chemotherapy. 54: 3505-8. PMID 20516280 DOI: 10.1128/AAC.00227-10  0.92
2010 Nett JE, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. The Journal of Infectious Diseases. 202: 171-5. PMID 20497051 DOI: 10.1086/651200  0.92
2010 Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 1559-67. PMID 20450350 DOI: 10.1086/652768  0.92
2010 Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 1091-100. PMID 20218877 DOI: 10.1086/651263  0.92
2010 Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 1101-11. PMID 20218876 DOI: 10.1086/651262  0.92
2009 Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Balajee SA, Pappas PG, Moser SA. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. Journal of Clinical Microbiology. 47: 3271-5. PMID 19692558 DOI: 10.1128/JCM.00854-09  0.92
2009 Hsu J, Andes DR, Knasinski V, Pirsch J, Safdar N. Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients European Journal of Clinical Microbiology and Infectious Diseases. 28: 1343-1351. PMID 19669657 DOI: 10.1007/s10096-009-0787-4  0.92
2009 Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, Nantel A, Andes DR, Johnson AD, Mitchell AP. Biofilm matrix regulation by Candida albicans Zap1. Plos Biology. 7: e1000133. PMID 19529758 DOI: 10.1371/journal.pbio.1000133  0.92
2009 Nett JE, Lepak AJ, Marchillo K, Andes DR. Time course global gene expression analysis of an in vivo Candida biofilm. The Journal of Infectious Diseases. 200: 307-13. PMID 19527170 DOI: 10.1086/599838  0.92
2009 Van Wart SA, Andes DR, Ambrose PG, Bhavnani SM. Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients. Diagnostic Microbiology and Infectious Disease. 63: 409-14. PMID 19249182 DOI: 10.1016/j.diagmicrobio.2009.01.027  0.92
2009 Baddley JW, Ostrosky-Zeichner L, Bhavnani SM, Andes DR. Authors' reply Antimicrobial Agents and Chemotherapy. 53: 2705-2706. DOI: 10.1128/AAC.01411-08  0.92
2008 Craig WA, Andes DR. In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models Antimicrobial Agents and Chemotherapy. 52: 3492-3496. PMID 18676887 DOI: 10.1128/AAC.01273-07  0.92
2008 Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, Andes DR, Mitchell AP. Complementary adhesin function in C. albicans biofilm formation. Current Biology : Cb. 18: 1017-24. PMID 18635358 DOI: 10.1016/j.cub.2008.06.034  0.92
2008 Andes DR, Diekema DJ, Pfaller MA, Marchillo K, Bohrmueller J. In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model Antimicrobial Agents and Chemotherapy. 52: 3497-3503. PMID 18625768 DOI: 10.1128/AAC.00478-08  0.92
2008 Baddley JW, Patel M, Bhavnani SM, Moser SA, Andes DR. Association of fluconazole pharmacodynamics with mortality in patients with candidemia. Antimicrobial Agents and Chemotherapy. 52: 3022-8. PMID 18591269 DOI: 10.1128/AAC.00116-08  0.92
2008 Nett JE, Guite KM, Ringeisen A, Holoyda KA, Andes DR. Reduced biocide susceptibility in Candida albicans biofilms. Antimicrobial Agents and Chemotherapy. 52: 3411-3. PMID 18573927 DOI: 10.1128/AAC.01656-07  0.92
2008 LaPlante KL, Leonard SN, Andes DR, Craig WA, Rybak MJ. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models. Antimicrobial Agents and Chemotherapy. 52: 2156-62. PMID 18411321 DOI: 10.1128/AAC.01046-07  0.92
2007 Gauthier GM, Safdar N, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transplant Infectious Disease : An Official Journal of the Transplantation Society. 9: 310-7. PMID 17428278 DOI: 10.1111/j.1399-3062.2007.00227.x  0.92
2006 Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryotic Cell. 5: 1604-10. PMID 17030992 DOI: 10.1128/EC.00194-06  0.92
2006 Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, Edwards JE, Filler SG, Mitchell AP. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. Plos Pathogens. 2: e63. PMID 16839200 DOI: 10.1371/journal.ppat.0020063  0.92
2006 Smith J, Andes DR. Pharmacokinetics of antifungals: Implications for drug selection Infections in Medicine. 23: 328-333.  0.92
2005 Bhavnani SM, Andes DR. Gemifloxacin for the treatment of respiratory tract infections: in vitro susceptibility, pharmacokinetics and pharmacodynamics, clinical efficacy, and safety. Pharmacotherapy. 25: 717-40. PMID 15899734 DOI: 10.1592/phco.25.5.717.63583  0.92
2005 Cirz RT, Chin JK, Andes DR, de Crécy-Lagard V, Craig WA, Romesberg FE. Inhibition of mutation and combating the evolution of antibiotic resistance. Plos Biology. 3: e176. PMID 15869329 DOI: 10.1371/journal.pbio.0030176  0.92
2004 Ulijasz AT, Andes DR, Glasner JD, Weisblum B. Regulation of iron transport in Streptococcus pneumoniae by RitR, an orphan response regulator. Journal of Bacteriology. 186: 8123-36. PMID 15547286 DOI: 10.1128/JB.186.23.8123-8136.2004  0.92
2003 Adams ML, Andes DR, Kwon GS. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity. Biomacromolecules. 4: 750-7. PMID 12741794 DOI: 10.1021/bm0257614  0.92
2002 Jones RN, Andes DR, Mandell LA, Gothelf S, Ehrhardt AF, Nicholson SC. Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease. 44: 93-100. PMID 12376038 DOI: 10.1016/S0732-8893(02)00448-0  0.92
1999 Andes DR, Craig WA. Pharmacokinetics and pharmacodynamics of antibiotics in meningitis Infectious Disease Clinics of North America. 13: 595-618. PMID 10470557 DOI: 10.1016/S0891-5520(05)70096-9  0.92
1998 Andes DR, Urban AW, Acher CW, Maki DG. Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter American Journal of Medicine. 105: 446-450. PMID 9831430 DOI: 10.1016/S0002-9343(98)00287-3  0.92
1998 Andes DR, Craig WA. Pharmacodynamics of fluoroquinolones in experimental models of endocarditis Clinical Infectious Diseases. 27: 47-50. PMID 9675448  0.92
1995 Craig WA, Andes DR. Parenteral versus oral antibiotic therapy Medical Clinics of North America. 79: 497-508. PMID 7752724  0.92
Show low-probability matches.